Gathered for "Genome Day" - TGG Editorial Team Attended BIT’s 2nd Annually International Congress of Genetics-2017

BIT’s 2nd Annually International Congress of Genetics (ICG) was held from April 25th to 27th 2017 in Xi’an, China. Occurring annually, ICG is a significant academic conference in the field of genetics and genomics. The editorial team (Carrie Wang, the assistant editor; Xue Kou, the market assistant editor) of TGG also took part in the conference, which was attended by more than 800 representatives from 30 countries and regions. International experts from academia and industry gathered for presentations and in-depth discussions of exciting new discoveries from the fields of human genetics, animal genetics, plant genetics, microbial genetics, epigenetics, and mitochondrial genetics. The conference promoted the exchange of information on the most advanced academic perspectives and research results as well as cutting-edge advances in diagnostics and technologies from all over the world.
Prof. Guangju Zhai, an associate editor for TGG, was an invited speaker at the conference. A Professor of Genetics at Memorial University of Newfoundland, Prof. Zhai’s research mainly focuses on the pathogenesis and etiology of osteoarthritis; population genetic structure of Newfoundland & Labrador and metabolomics and genomics of complex traits. On the second day of the conference, he gave a presentation titled “Metabolomics of Osteoarthritis-Novel Metabolic Markers and Their Clinical Utility” and discussed his findings further with a few experts. Following the presentation, he gave a brief introduction of TGG, including the goal of “promoting basic research into clinical applications of genetics and genomics” and vision of developing into an academic journal with high quality and influence.
Prof. Susana C. Raimondi from St. Jude Children's Research Hospital, delivered a presentation on “Cytogenetics and Molecular Lesions in Acute Leukemias”. She highlighted the pathogenesis and clinical significance of cytogenetics and molecular lesions in acute leukemia with detailed cases and data. Her views won recognition from the experts present. We had a keen interest in Dr. Raimondi’s lecture and were honored that she accepted our invitation to give a brief interview. During the interview, she carefully and enthusiastically answered every question, which including a discussion of existing problems and greatest challenges facing the current standard of care for leukemia. By communicating with Prof. Raimondi, we gained a better understanding of the current status and treatment prospects for acute leukemia. The video for the complete interview is enclosed.
The conference allowed the TGG editorial team to learn more about the domestic and international research status, hot topics on genetics, and research progress in related fields, as well as new ideas for TGG’s future development. A number of experts gave approval for TGG’s emphasis on translational research and voiced that they will consider giving support to TGG. Our most sincere thanks to all the experts’ who offered to support TGG. It takes ten years to sharpen a sword. We will continue to do our best to repay your support with the growth of TGG.
Interview questions:
1. You made a wonderful speech on Cytogenetics and Molecular Lesions in Acute Leukemias. Could you kindly briefly summarize your speech?
2. As for acute leukemia patient, there are chemotherapy, radiotherapy and stem cell transplantation to choose, do you think which one is the best?
3. What do you think is the biggest challenge in the treatment of acute leukemia at present?

Professor Nils-Claudius Gellrich’s Bio:
Prof. Susana C. Raimondi, director of the Cytogenetics Laboratory at St. Jude Children Research Hospital in USA, is responsible for cytogenetics and molecular cytogenetic studies in childhood neoplasia. Prof. Raimondi is also a founding fellow of American College of Medical Genetics. Her current area of interest is understanding of subtle/cryptic chromosomal rearrangements that escape conventional cytogenetics detection. Development of Fluorescence in situ Hybridization (FISH) testing of paraffin embedded tissues for brain and solid tumors.
Quick Links
  • OAE Publishing Inc. (OAE) is an online open-access publisher specializing in the publication of biomedical peer-reviewed journals...

  • Contact us
  • Leave feedback
Copyright © 2017 OAE Publishing Inc. All Rights Reserved.